Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight

Johnson & Johnson proposes a $5.5 billion settlement to resolve remaining lawsuits claiming its talc products caused ovarian cancer, requiring 95% claimant participation. The company previously rejected a $9 billion settlement proposal and faced challenges proving no direct link between its products and cancer, but the new deal aims to end the decade-long legal battle.